跳到主要内容

SOLENO THERAPEUTICS INC (SLNO) Stock Forecast 2025 - AI Price Prediction & Analysis


SOLENO THERAPEUTICS INC (SLNO) AI Stock Price Forecast & Investment Analysis

SOLENO THERAPEUTICS INC Stock Price Chart and Technical Analysis

Loading SOLENO THERAPEUTICS INC interactive price chart and technical analysis...

SOLENO THERAPEUTICS INC (SLNO) - Comprehensive Stock Analysis & Investment Research

Deep dive into SOLENO THERAPEUTICS INC's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about SOLENO THERAPEUTICS INC, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For SOLENO THERAPEUTICS INC: SOLENO THERAPEUTICS INC operates in the Industrial Applications and Services sector, establishing it as a mid-cap growth opportunity.

SOLENO THERAPEUTICS INC (Stock Symbol: SLNO) is a leading company in the Industrial Applications and Services sector , specifically operating within the Electromedical & Electrotherapeutic Apparatus industry.

The organization employs approximately 27 professionals worldwide .

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing SOLENO THERAPEUTICS INC's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For SOLENO THERAPEUTICS INC:

Market Capitalization: $4417 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Return on Equity (ROE): -86.5% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for SOLENO THERAPEUTICS INC stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For SOLENO THERAPEUTICS INC: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for SOLENO THERAPEUTICS INC stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: SOLENO THERAPEUTICS INC's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For SOLENO THERAPEUTICS INC: Market positioning analysis based on available financial and operational metrics.

SOLENO THERAPEUTICS INC strategically competes in the highly dynamic Electromedical & Electrotherapeutic Apparatus marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

SOLENO THERAPEUTICS INC (SLNO) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for SOLENO THERAPEUTICS INC stock analysis.

Loading SOLENO THERAPEUTICS INC comprehensive fundamental analysis and insider trading data...

Deep dive into SOLENO THERAPEUTICS INC's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if SOLENO THERAPEUTICS INC stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For SOLENO THERAPEUTICS INC: With a P/E ratio of -18.46, the market sees the stock as potentially undervalued.

P/E Ratio -18.46x
P/B Ratio 19.02x
Market Cap $4417M
EPS $-2.71
Book Value/Share $4.79
Revenue/Share $0.01
FCF/Share $-0.44
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently SOLENO THERAPEUTICS INC converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For SOLENO THERAPEUTICS INC: An ROE of -86.5% indicates room for improvement in shareholder value creation.

ROE -86.5%
ROA -55.8%
ROIC -86.1%
Operating Margin -27409.4%
Net Margin -19806.0%
EBT Margin 7.2%
Tax Rate 16.0%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess SOLENO THERAPEUTICS INC's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For SOLENO THERAPEUTICS INC: A current ratio of 4.10 indicates strong liquidity.

Current Ratio 4.10x
Quick Ratio 3.96x
D/E Ratio 0.01x
Financial Leverage 1.61x
Interest Coverage 1.6x
Working Capital $42M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal SOLENO THERAPEUTICS INC's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For SOLENO THERAPEUTICS INC: Free cash flow of $-27M indicates cash challenges that need attention.

Operating Cash Flow $-27M
Free Cash Flow $-27M
FCF/Sales 36.6%
CapEx/Sales 3.9%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively SOLENO THERAPEUTICS INC uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For SOLENO THERAPEUTICS INC: An asset turnover of 0.59x suggests room for improvement in asset utilization.

Asset Turnover 0.59x
Receivables Turnover 45.0x
Inventory Turnover 2.5x
Fixed Assets Turnover 8.5x
Days Sales Outstanding 8 days
Days Inventory 146 days
Payables Period 71 days
Cash Conversion Cycle 34 days
Understanding Financial Statement Data

What these metrics mean: Key figures from SOLENO THERAPEUTICS INC's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For SOLENO THERAPEUTICS INC:

Income Statement ($ Millions)
Operating Income $-142M
Net Income $-131M
R&D Expense $66M
SG&A Expense $14M
Cost of Goods Sold $0M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 70%
Cash & Short-term Investments 68%
Total Liabilities 38%
Short-term Debt 1%
Accounts Receivable 67%
Inventory 12%
Dividend & Shareholder Information
Shares Outstanding 49M
Growth Metrics (YoY)
EPS Growth -5.5%

Latest SOLENO THERAPEUTICS INC Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting SOLENO THERAPEUTICS INC (SLNO) stock price and investment outlook.

, source: Insider Monkey

We recently published a list of 10 Stocks Jump, Defy Market Uncertainties on Thursday. In this article, we are going to take a look at where Soleno Therapeutics Inc. (NASDAQ:SLNO) stands against other ...

SOLENO THERAPEUTICS INC Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of SOLENO THERAPEUTICS INC against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AXGN Unlock Forecast - 30 Days FREE Trial $751M -41.7x 6.7x
BLFS Unlock Forecast - 30 Days FREE Trial $991M -14.7x 2.8x
BSGM Unlock Forecast - 30 Days FREE Trial $126M -1.8x 48.5x
CBLL Unlock Forecast - 30 Days FREE Trial $438M x 2.5x
CNMD Unlock Forecast - 30 Days FREE Trial $1647M 15.0x 1.6x
CUTR Unlock Forecast - 30 Days FREE Trial $9M -0.1x 0.0x
CV Unlock Forecast - 30 Days FREE Trial $0M x x
ECOR Unlock Forecast - 30 Days FREE Trial $37M -7.3x 32.8x
EDAP Unlock Forecast - 30 Days FREE Trial $99M x 2.4x
ELMD Unlock Forecast - 30 Days FREE Trial $218M 28.9x 5.1x
FONR Unlock Forecast - 30 Days FREE Trial $99M 9.5x 0.6x
GTHP Unlock Forecast - 30 Days FREE Trial $22M x x
HSDT Unlock Forecast - 30 Days FREE Trial $66M 0.0x 51.9x
HYPR Unlock Forecast - 30 Days FREE Trial $148M -1.8x 0.9x
INMD Unlock Forecast - 30 Days FREE Trial $1195M x 1.7x
IRIX Unlock Forecast - 30 Days FREE Trial $24M -2.8x 3.9x
IRME Unlock Forecast - 30 Days FREE Trial $1M x x
ITGR Unlock Forecast - 30 Days FREE Trial $3631M 43.9x 2.1x
LIVN Unlock Forecast - 30 Days FREE Trial $3069M -662.0x 2.7x
MASI Unlock Forecast - 30 Days FREE Trial $8094M 128.1x 7.8x
MDT Unlock Forecast - 30 Days FREE Trial $121632M 26.1x 2.5x
MOVE Unlock Forecast - 30 Days FREE Trial $5M -8.6x 0.7x
NDRA Unlock Forecast - 30 Days FREE Trial $2M -0.8x 1.1x
NRXS Unlock Forecast - 30 Days FREE Trial $24M -0.9x 5.6x
NUWE Unlock Forecast - 30 Days FREE Trial $65M -0.1x 18.1x
NXL Unlock Forecast - 30 Days FREE Trial $15M -4.7x 2.4x
NXLIW Unlock Forecast - 30 Days FREE Trial $5M x 1.0x
OM Unlock Forecast - 30 Days FREE Trial $249M -0.4x 1.6x
POCI Unlock Forecast - 30 Days FREE Trial $36M -11.5x 2.8x
QTI Unlock Forecast - 30 Days FREE Trial $7M -0.4x -0.8x
SLNO Unlock Forecast - 30 Days FREE Trial $4417M -18.5x 19.0x
SMLR Unlock Forecast - 30 Days FREE Trial $385M 10.4x 1.0x
STRR Unlock Forecast - 30 Days FREE Trial $7M -1.6x 0.1x
STRRP Unlock Forecast - 30 Days FREE Trial $31M -5.5x 0.5x
STXS Unlock Forecast - 30 Days FREE Trial $1182M -8.4x 811.5x
TIVC Unlock Forecast - 30 Days FREE Trial $3M 0.0x 0.8x
TMDX Unlock Forecast - 30 Days FREE Trial $4610M 64.3x 14.5x
VANI Unlock Forecast - 30 Days FREE Trial $92M -2.7x 7.9x
VASO Unlock Forecast - 30 Days FREE Trial $21M 20.1x 0.8x
ZYXI Unlock Forecast - 30 Days FREE Trial $46M 41.4x 36.5x

Frequently Asked Questions - SOLENO THERAPEUTICS INC Stock Forecast

How accurate are SOLENO THERAPEUTICS INC stock predictions?

Our AI model demonstrates -8% historical accuracy for SLNO predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence SOLENO THERAPEUTICS INC stock price forecasts?

Our analysis considers SOLENO THERAPEUTICS INC's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is SOLENO THERAPEUTICS INC a good investment in 2025?

Based on our AI analysis, SOLENO THERAPEUTICS INC shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are SOLENO THERAPEUTICS INC forecasts updated?

SOLENO THERAPEUTICS INC stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced SOLENO THERAPEUTICS INC Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for SOLENO THERAPEUTICS INC stock.

My Portfolio

Investment Dashboard

Loading your portfolio...